NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its first-quarter revenues rose 19 percent year over year as reagent and disposable sales increased 22 percent.

The Sunnyvale, Calif.-based firm said that total revenues came in at $91.9 million, up from $77.3 million a year ago, and topping the average analyst estimate of $89.1 million.

Reagent and disposable sales shot up to $75.9 million from $62.1 million a year ago, while system and other sales increased 5 percent to $16.0 million from $15.2 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.